Teleflex Incorporated (NYSE:TFX) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 3.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,875 shares of the medical technology company’s stock after selling 382 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Teleflex were worth $1,758,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the business. Avior Wealth Management LLC raised its holdings in Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 101 shares in the last quarter. True Wealth Design LLC raised its stake in shares of Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after buying an additional 166 shares in the last quarter. IFP Advisors Inc lifted its holdings in shares of Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after buying an additional 217 shares during the period. Exchange Traded Concepts LLC grew its holdings in Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after acquiring an additional 94 shares during the period. Finally, R Squared Ltd bought a new stake in Teleflex in the fourth quarter worth about $64,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE TFX opened at $139.35 on Wednesday. The stock has a 50-day simple moving average of $161.64 and a 200 day simple moving average of $192.23. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.91. The stock has a market capitalization of $6.46 billion, a PE ratio of 27.70, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Analyst Ratings Changes

A number of research firms recently commented on TFX. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Piper Sandler reiterated a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Truist Financial dropped their price target on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research note on Monday, March 3rd. Finally, Morgan Stanley reduced their price objective on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research note on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and an average target price of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.